Metabotropic g-aminobutyric acid receptors (GABA B Rs) play a critical role in inhibitory synaptic transmission in the hippocampus. However, little is known about a possible long-term effect requiring transcriptional changes. Here, using microarray technology and RT-PCR of RNA from cultured rat embryonic hippocampal neurones, we report the profile of genes that are up-or down-regulated by activation of GABA B Rs by baclofen but are not changed by baclofen in the presence of the GABA B R CGP55845A. Our data show for the first time regulation of transcription of defined mRNAs following specific GABA B receptor activation. The identified genes can be grouped into those encoding signal transduction, endocytosis/trafficking and structural classes of proteins. For example, butyrylcholinesterase (BuChE), brain-derived neurotrophic factor (BDNF) and COPS5 (Jab1) genes were up-regulated whereas Rab8 interacting protein and Rho GTPase activating protein 4 (ARHGAP4) were down-regulated.
Introduction
g-amino butyric acid (GABA), the predominant inhibitory neurotransmitter in the CNS, can act at two distinct types of receptors, the fast ligand-gated ionotropic GABA A and GABA c receptors and slower G protein-linked, metabotropic GABA B receptors (GABA B R; (20, 22, 25) ).
GABA B Rs have both pre-and postsynaptic distributions in the mammalian brain. Presynaptic GABA B Rs suppress neurotransmitter release by inhibiting voltage-sensitive P, N, and L-type Ca 2+ channels (19, 25, 31, 35) . Postsynaptic GABA B R stimulation generally causes inhibition of adenylate cyclase (45) and activation of hyper-polarizing potassium channels (23, 38) .
In addition to playing fundamental roles in regulating basic neurotransmission GABA B Rs are also involved in synaptic plasticity and nociception (for reviews see (6, 7, 10, 29) . GABA B R activation can also initiate long-term effects on protein synthesis and has, for example, been reported to negatively regulate CREB-mediated transcription in the CNS (4, 39) . GABA B Rs have been implicated in the development of some neuronal pathways. For example, GABA B1 and GABA B2 subunits are present in the rat neocortex from embryonic day 14 (E14) suggesting that functional GABA B Rs are present during prenatal development in vivo (27) . It has been reported that during corticogenesis in the rat CNS cortical plate cells release GABA which acts as a chemoattractant for GABA B R-containing ventricular zone neurones migrating from germinal regions (5) . GABA and the selective GABA B R agonist baclofen both stimulate
Xenopus retinal ganglion cell neurite outgrowth in culture and GABA B R antagonists applied to the developing optic projection in vivo cause a dose-dependent shortening of the optic nerve (15) . These studies suggest that GABA B R activation can result in changes in protein synthesis but little is known about the target genes or long-term effects involving alterations at the genomic level.
To gain insight into the pathways by which GABA B R activation may influence long-term changes in synaptic plasticity and neuronal growth and morphology we investigated changes in gene expression in cultured hippocampal neurones in the presence of TTX evoked by the
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4 GABA B R agonist baclofen. We used cDNA microarray gene expression profiling (12, 14, 34) to identify candidate genes that are differentially expressed in cultured hippocampal neurones following GABA B R activation. Overall the microarray analysis suggested increased levels of transcription of 14 genes and decreased transcription of 6 genes. Importantly, none of these genes displayed any change in expression when baclofen was applied in the presence of the GABA B R-specific antagonist CGP55845A. Our results show that the expression of several different classes of genes alters following baclofen application.
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Materials and Methods
Cell Culture: Hippocampal cultures were prepared as previously described (21). Briefly, hippocampi from E18 Wistar rats were dissected and the neurons dissociated by enzymatic digestion with trypsin for 15 min and mechanical dissociation. Cells were then plated at a density of 500,000 per 60 mm diameter poly-L-lysine (1mg/ml; Sigma) coated dish. The culture medium was composed of Neurobasal medium (Gibco) supplemented with horse serum (10%), B27 (Gibco) and 2 mM glutamine. On the second day, the media was changed for Neurobasal medium supplemented with B27 and neurons were then fed each week with this glutamine free medium until use. Cultures were maintained at 37 C in 5% CO2 humidified incubator and used for experiments at 21 day in vitro (DIV). Control and experimental group cultures were incubated with 10 mM tetrodotoxin (TTX) for 15 min followed by addition of 100mM baclofen, 100mM baclofen plus 10 µM CGP55845A or vehicle alone. TTX was used to ensure that the effects observed are directly attributable GABA B R activation rather than down-stream events caused by depression of synaptic transmission. This could occur if experiments were done in the absence of TTX since baclofen activation of inhibitory GABA B Rs would reduced intrinsic neuronal activity compared to the control conditions (vehicle or baclofen + CGP55845A).
Total RNA preparation: Each experimental group was compared as replicates of three. For each replicate different batches of cultured hippocampal neurones were harvested after 2 hours incubation +/-baclofen or baclofen + CGP55845A and total RNA was isolated using RNeasy Mini kit (Qiagen, UK) according to the manufacturer's protocol. All RNA samples were treated with DNase to remove any contaminating genomic DNA using DNA-free kit (Ambion, UK) according to the manufacturer's protocol.
Microarray Target Labelling and Hybridisation: Targets for cDNA microarrays were generated using 5 mg of total RNA from control and baclofen treated cultured hippocampal neurones in a standard reverse transcription (RT) reaction. RNA was annealed, in 16 ml Assuming a normal distribution profile, z differences are assigned significance according to their relation to the calculated standard deviation of all the z differences in any one comparison. In order to facilitate comparison of z differences between several different experiments, z differences were divided by the appropriate standard deviation to give the zratios (41) . All microarry data has been submitted to the GEO database maintained by the National Center for Biotechnology (NCBI) (13) (http://www.ncbi.nlm.nih.gov/geo/) and can be accessed using the following accession numbers:GSM28446, GSM28534, GSM28535, GSM28536, GSM28537, GSM28538.
Multiplex Reverse Transcriptase (RT)-PCR:
A two-step semi-quantitative RT-PCR was employed for validation as follows. First strand cDNA was synthesized using RETROscript TM kit (Ambion, Huntingdon, UK) in a final volume of 20 ml containing 1x RT buffer, 1.5 mg of total RNA, 5 mM random decamers primer, 200 mM dNTPs and 100U of MMLV-reverse transcriptase.
For the PCR, gene-specific primers were generated based on the rat gene sequence. Primers specific for 18S were added as an internal control following the manufacturer's protocol were subjected to 2% agarose gel electrophoresis. Gels were stained using Syber Gold (Molecular Probes, Leiden, The Netherlands) and images were captured using a gel documentation system (GDS-8000 System, UVP BioImaging Systems, Cambridge, UK). PCR bands were quantified using Image J software (NIH, Bethesda, MD). All of the RT-PCR experiments were conducted in triplicate using three separate RNA samples extracted from different culture preparations.
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Statistics:
RT-PCR data were analysed by an unpaired two tailed Student's t test. Results were considered significant when p value were <0.05.
Results

Microarray findings:
The cDNA microarray used in the present study is the National Institute on Aging Neuroarray. This array contains 1152 genes relevant to neurobiology. NIA Neuroarray probes were hybridised in triplicate with targets derived from control and baclofen-treated cultured hippocampal neurones. Data analysis by Z-normalisation of the hybridisation signals identified 20 candidate regulated genes. Fourteen of these genes were up-regulated by specific GABA B receptor activation and six were down-regulated ( Table 1 ).
The identified genes can be grouped into the following general protein categories:
Cell signalling proteins. The group of genes involved in cell signalling represents the most hits 
RT-PCR validation:
To confirm the array data, we selected six of the most potentially interesting genes and semi-quantitatively (3) assessed their differential expression in the hippocampal mRNA of cultured neurones by using multiplex RT-PCR (Figs. 1, 2 ). Three separate mRNA samples, extracted from different culture preparations, for each experimental group were used in the RT-PCR. Out of the six genes, the mRNAs for five were significantly altered following baclofen treatment in the rtPCR assays. Consistent with the microarray data, BchE, BDNF and COPS5/ Jab1 were up-regulated. Whereas ARHGAP4 and Rab8 interacting Protein were down-regulated. Although the beta-2-adrenergic receptor (ADRB2) showed a trend to increase in mRNA levels in the PCR assays, this increase was not significant (data not shown). It is important to note that the fold of change obtained by the PCR assays is smaller than z-ratios in the array data. This is because the z-ratios (41) are z-differences divided by standard deviation and not fold of change ratios.
Discussion
Microarray analysis provides the means to perform parallel analysis of multiple genes in a single assay (26, 47) resulting in a semi-quantitative assessment of changes in gene expression. They represent a powerful tool to investigate alterations in mRNA levels which accompany, and may regulate, physiological change. Our cDNA microarray analysis revealed 20 genes as being differentially expressed in the hippocampal neuronal as a consequence of specific GABA B R activation ( Table 1 
Brain-derived neurotropic factor (BDNF):
BDNF is a neurotrophin that can regulate neuronal survival via high-affinity membrane tyrosine kinase receptors (trk; (17)). It is widely distributed in the central nervous system (CNS) and, in addition to its survival-promoting actions on a variety of CNS neurones, the interplay between BDNF and signal transduction modulators has been suggested to play a key role in certain types of synaptic-plasticity (42) . BDNF is a molecular target of CREB and, in turn, can regulate CREB transcription as well as synapsin I a protein that is involved in synaptic transmission.
We show that BDNF expression is increased by ~200% by baclofen, a GABA B R agonist. It Baclofen reduces the transcriptional stimulation evoked by both forskolin and KCl (4).
Specifically, in cerebellar granule neurones the specific agonist baclofen inhibits forskolininitiated CREB-transcriptional programs by lowering cytosolic cAMP or Ca 2+ levels (4).
Although we did not detect a baclofen-evoked alteration in the expression of the transcription factor ATF4 (CREB2) we and others have shown that CREB2 binds directly to the GABA B R1
subunit via the coiled-coil domains present in both proteins (32, 43, 44). We found that activation of GABA B Rs in hippocampal neurones caused a dramatic translocation of ATF4 out of the nucleus into the cytoplasm (but see (44)) suggesting that this interaction could represent a novel neuronal signaling pathway. A possible role for the GABA B R-ATF4 interaction is in gene regulation (48) . ATF4 is a member of a family of cAMP response element binding proteins that has been shown to negatively regulate CREB (1, 2, 46) . CREB itself has been widely implicated in memory formation and, interestingly, CREB is activated during longterm potentiation and other forms of synaptic plasticity (1, 37) . Therefore, docking of ATF4 to somatodendritic GABA B R could prevent its nuclear function and thereby effect the transcriptional regulation of proteins. In this way GABA B Rs may influence the expression of
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COPS5 / Jab1:
COPS5 is one of the eight subunits of COP9 signalosome, a highly conserved protein complex that functions as an important regulator in multiple signaling pathways. The COP9 signalosome can act as a positive regulator of E3 ubiquitin ligases. It can also act as a coactivator that increases the specificity of Jun/AP1 transcription factors, specifically, COPS5 selectively potentiates transactivation by c-Jun or JunD and stabilizes their complexes with AP-1 sites and increase the specificity of target gene activation by AP-1 proteins (9). COPS5 binds to and induces specific down-regulation of the cyclin-dependent kinase inhibitor p27, a central mediator in the imposition and maintenance of quiescence in cell cycle (8 , 40) . The physiological implications of our finding that activation of GABA B Rs increases COPS5 expression remain unclear. However, it is intriguing that this protein is involved in the regulation of ubiquitination, a process that tags membrane proteins for internalisation and/or degradation, and also cell quiescence. Modulation of these pathways, for example by removal of excitatory channels or receptors would be consistent with a model in which GABA B R activity could dampen down cell activity in the long-term.
Rho GTPase activating protein 4 (ARHGAP4):
Rho GTPases are molecular switches that control many cellular functions via the regulation of the actin cytoskeleton (28). In neurones they are involved in neuronal migration, growth cone guidance and synaptic formation (28).
Rho GTPase activating proteins are modulators of Rho GTPase activity in neurones (16) .
ARHGAP4 can stimulate the GTPase activity of three members of Rho GTPases, Rac1, Cdc42
and RhoA (16) . ARHGAP4 mRNA is expressed at high levels throughout the developing and adult CNS but protein levels are most abundant in specific regions including the hippocampus (16) . In resting neurones ARHGAP4 associates with the Golgi complex and is also present in the tips of differentiating neurites of PC12 cells (16) . The fact that baclofen evoked a decrease in ARHGAP4 mRNA levels suggests that GABA B R activation may reduce the one or more of In conclusion, we show that baclofen application to neuronal cultures in the presence of TTX alters the transcription of 20 out of the 1152 genes interrogated. Expression of these genes was unchanged when the GABA B R-specific antagonist CGP55845A was also included. While this represents only a fraction of the total number of genes of the rat genome, a number of interesting and potentially important changes have been identified. These novel data on downstream, late phase consequences of GABA B R signalling provide a basis for future studies to investigate these changes in gene expression at the protein, cell biology and functional levels. group. An independent RNA pool was used for each replicate. 
